P0781 : High SVR rates despite multiple negative predictors in genotype 1 patients receiving ombitasvir/paritaprevir/R, dasabuvir with or without ribavirin for 12 and 24 weeks: Integrated analysis of six phase 3 trials.

Authors :: Reau, N.
Fried, M.W
Wedemeyer, H.
Cooper, C.
Diago, M.
Craxi, A.
Strasser, S.
Dufour, J.-F.
Xie, W.
Larsen, L.
Dumas, E.O.
Bernstein, D.
Source :: Journal of Hepatology. Apr2015 Supplement 2, Vol. 62, pS623-S624. 1p.
Publication Year :: 2015

Subjects :: *HEPATITIS C treatment
*ANILIDES
*MACROCYCLIC compounds
*SULFONAMIDES
*RIBAVIRIN
*CLINICAL trials

Full Text Access

Tools